Study touts benefits of imaging agent regadenoson

12/3/2009 | (free registration)

A study of patients with end-stage renal disease found that regadenoson, a vasodilator stress myocardial perfusion imaging agent, is safe and tolerable and is comparable to adenosine. "Unlike adenosine, it can be safely employed in patients with moderate airway disease or asthma," the lead investigator said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY